Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Abeona Therapeutics (ABEO) Revenue (2016 - 2025)

Historic Revenue for Abeona Therapeutics (ABEO) over the last 13 years, with Q2 2025 value amounting to $400000.0.

  • Abeona Therapeutics' Revenue changed N/A to $400000.0 in Q2 2025 from the same period last year, while for Sep 2025 it was $400000.0, marking a year-over-year change of. This contributed to the annual value of $3.5 million for FY2023, which is 14752.48% up from last year.
  • Latest data reveals that Abeona Therapeutics reported Revenue of $400000.0 as of Q2 2025.
  • In the past 5 years, Abeona Therapeutics' Revenue registered a high of $3.5 million during Q2 2023, and its lowest value of -$1.5 million during Q2 2021.
  • Moreover, its 4-year median value for Revenue was $68000.0 (2022), whereas its average is $185555.6.
  • Its Revenue has fluctuated over the past 5 years, first plummeted by 13666.67% in 2021, then skyrocketed by 25000.0% in 2023.
  • Over the past 4 years, Abeona Therapeutics' Revenue (Quarter) stood at -$48000.0 in 2021, then surged by 241.67% to $68000.0 in 2022, then skyrocketed by 5047.06% to $3.5 million in 2023, then tumbled by 88.57% to $400000.0 in 2025.
  • Its last three reported values are $400000.0 in Q2 2025, $3.5 million for Q2 2023, and $68000.0 during Q4 2022.